Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Mirikizumab for Pediatric Crohn's Disease
Recruiting2 awardsPhase 3
Los Angeles, California
This trial will evaluate an experimental drug to treat Crohn's disease in children. Participants will randomly be assigned to receive the drug or another intervention. The study will last 74 weeks with up to 19 visits.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service